Chartwell Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHARTWELL, and what generic and branded alternatives to CHARTWELL drugs are available?
CHARTWELL has five hundred and thirty-six approved drugs.
There are three tentative approvals on CHARTWELL drugs.
Drugs and US Patents for Chartwell
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | FLUOCINONIDE | fluocinonide | OINTMENT;TOPICAL | 207538-001 | Jul 31, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET;ORAL | 079050-006 | May 29, 2008 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Rx | CEFPROZIL | cefprozil | TABLET;ORAL | 065235-001 | Nov 14, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Chartwell Molecular | PREDNISONE | prednisone | TABLET;ORAL | 080514-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Chartwell Rx | SULINDAC | sulindac | TABLET;ORAL | 072713-001 | Aug 30, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Chartwell Rx | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 076908-002 | Mar 12, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Chartwell
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chartwell Rx | MOBAN | molindone hydrochloride | TABLET;ORAL | 017111-005 | Approved Prior to Jan 1, 1982 | 3,491,093 | ⤷ Sign Up |
Chartwell Rx | MOBAN | molindone hydrochloride | TABLET;ORAL | 017111-006 | Approved Prior to Jan 1, 1982 | 3,491,093 | ⤷ Sign Up |
Chartwell Molecular | MYKROX | metolazone | TABLET;ORAL | 019532-001 | Oct 30, 1987 | 4,517,179 | ⤷ Sign Up |
Chartwell Rx | MOBAN | molindone hydrochloride | TABLET;ORAL | 017111-007 | Approved Prior to Jan 1, 1982 | 3,491,093 | ⤷ Sign Up |
Chartwell Rx | LIMBITROL DS | amitriptyline hydrochloride; chlordiazepoxide | TABLET;ORAL | 016949-002 | Approved Prior to Jan 1, 1982 | 4,316,897 | ⤷ Sign Up |
Chartwell Rx | MOBAN | molindone hydrochloride | TABLET;ORAL | 017111-004 | Approved Prior to Jan 1, 1982 | 3,491,093 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.